Atrial Fibrillation (AF) stands as a common cardiac rhythm disorder marked by irregular and frequently accelerated heartbeats. This condition arises when the heart's upper chambers (atria) undergo a quivering or fluttering motion, disrupting the normal electrical impulses that coordinate heartbeats. Consequently, the heart may struggle to efficiently pump blood, potentially leading to complications like blood clots, strokes, or heart failure. Although AF can affect individuals of various age groups, its prevalence tends to increase with age, with factors such as hypertension, diabetes, and heart disease heightening the risk. Recognizable symptoms encompass palpitations, fatigue, dizziness, and shortness of breath. The timely identification and effective management of Atrial Fibrillation are pivotal in reducing associated risks and improving the quality of life for those impacted. Treatment approaches typically include medications, lifestyle adjustments, and, in specific cases, medical procedures designed to restore or regulate the heart's rhythm. Ongoing research efforts contribute to a growing understanding of AF mechanisms, offering promise for innovative treatment options and advancements in patient care.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : CARDIAC TROPONIN AND HOMOCYSTEINE LEVELS IN HEMODIALYSIS PATIENTS: ASSOCIATION WITH DIALYSIS VINTAGE AND CARDIOVASCULAR COMORBIDITY
Sofra Maria, Aretaieion University Hospital, Greece
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation